Suppr超能文献

糖尿病和肥胖症是胰腺癌的风险因素。

Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

出版信息

J Acad Nutr Diet. 2018 Apr;118(4):555-567. doi: 10.1016/j.jand.2017.07.005. Epub 2017 Sep 12.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The worldwide estimates of its incidence and mortality in the general population are eight cases per 100,000 person-years and seven deaths per 100,000 person-years, and they are significantly higher in the United States than in the rest of the world. The incidence of this disease in the United States is more than 50,000 new cases in 2017. Indeed, total deaths due to PDAC are projected to increase dramatically to become the second leading cause of cancer-related deaths before 2030. Considering the failure to date to efficiently treat existing PDAC, increased effort should be undertaken to prevent this disease. A better understanding of the risk factors leading to PDAC development is of utmost importance to identify and formulate preventive strategies. Large epidemiologic and cohort studies have identified risk factors for the development of PDAC, including obesity and type 2 diabetes mellitus. This review highlights the current knowledge of obesity and type 2 diabetes as risk factors for PDAC development and progression, their interplay and underlying mechanisms, and the relation to diet. Research gaps and opportunities to address this deadly disease are also outlined.

摘要

胰腺导管腺癌 (PDAC) 是最致命的癌症类型之一。全球普通人群中 PDAC 的发病率和死亡率估计分别为每 10 万人 8 例和每 10 万人 7 例,而在美国的发病率和死亡率均显著高于世界其他地区。2017 年美国 PDAC 的新发病例超过 5 万例。事实上,预计到 2030 年前,PDAC 导致的总死亡人数将大幅增加,成为癌症相关死亡的第二大主要原因。鉴于目前未能有效治疗现有的 PDAC,应加大力度预防这种疾病。更好地了解导致 PDAC 发展的危险因素对于确定和制定预防策略至关重要。大型流行病学和队列研究已经确定了 PDAC 发展的危险因素,包括肥胖和 2 型糖尿病。本综述重点介绍了肥胖和 2 型糖尿病作为 PDAC 发展和进展的危险因素、它们之间的相互作用和潜在机制,以及与饮食的关系。还概述了研究中的空白和解决这一致命疾病的机会。

相似文献

1
Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
J Acad Nutr Diet. 2018 Apr;118(4):555-567. doi: 10.1016/j.jand.2017.07.005. Epub 2017 Sep 12.
2
Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study.
Cancer Res. 2021 Mar 15;81(6):1616-1622. doi: 10.1158/0008-5472.CAN-20-2256. Epub 2021 Jan 29.
3
Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
Semin Oncol. 2015 Feb;42(1):8-18. doi: 10.1053/j.seminoncol.2014.12.002. Epub 2014 Dec 9.
5
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
Diabetes. 2017 May;66(5):1103-1110. doi: 10.2337/db16-1477.
6
A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials.
Pancreatology. 2022 Jan;22(1):98-111. doi: 10.1016/j.pan.2021.10.004. Epub 2021 Oct 26.
8
Epidemiology of pancreatic adenocarcinoma.
Chin Clin Oncol. 2017 Jun;6(3):24. doi: 10.21037/cco.2017.06.32.
9
Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
Cancer Sci. 2018 Oct;109(10):3013-3023. doi: 10.1111/cas.13766. Epub 2018 Sep 5.

引用本文的文献

1
Reversed Gender Burden of Pancreatic Cancer Attributable to High BMI: A GBD 2021 Analysis of 204 Countries with Projections to 2041.
Cancer Control. 2025 Jan-Dec;32:10732748251372674. doi: 10.1177/10732748251372674. Epub 2025 Aug 29.
3
Rising burden of pancreatic cancer in China: Trends, drivers, and future projections.
PLoS One. 2025 Jul 1;20(7):e0327009. doi: 10.1371/journal.pone.0327009. eCollection 2025.
4
Fatty Pancreas: Its Potential as a Risk Factor for Pancreatic Cancer and Clinical Implications.
Cancers (Basel). 2025 May 24;17(11):1765. doi: 10.3390/cancers17111765.
5
Can AI Be Useful in the Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes?
Biomedicines. 2025 Mar 31;13(4):836. doi: 10.3390/biomedicines13040836.
7
Pancreatic Steatosis as a Risk Factor for Pancreatic Ductal Adenocarcinoma: Pathogenesis and Clinical Implications.
Clin Transl Gastroenterol. 2025 Feb 24;16(6):e00832. doi: 10.14309/ctg.0000000000000832. eCollection 2025 Jun 1.
8
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients.
Neoplasia. 2025 Feb;60:101129. doi: 10.1016/j.neo.2025.101129. Epub 2025 Jan 21.
9
Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis.
Int J Mol Sci. 2024 Nov 13;25(22):12159. doi: 10.3390/ijms252212159.
10
A MR-PheWAS and bidirectional Mendelian randomization study: Exploring for causal relationships of pancreatic cancer.
Medicine (Baltimore). 2024 Oct 11;103(41):e40047. doi: 10.1097/MD.0000000000040047.

本文引用的文献

1
Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies.
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):45-55. doi: 10.1016/S2468-1253(16)30004-8. Epub 2016 Jun 28.
2
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):226-237. doi: 10.1016/S2468-1253(16)30106-6. Epub 2016 Oct 12.
3
4
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
Cancer Res. 2017 May 15;77(10):2647-2660. doi: 10.1158/0008-5472.CAN-16-1986. Epub 2017 Mar 1.
5
Associations between circulating levels of adipocytokines and abdominal adiposity in patients after acute pancreatitis.
Clin Exp Med. 2017 Nov;17(4):477-487. doi: 10.1007/s10238-017-0453-6. Epub 2017 Feb 6.
6
Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):914-922. doi: 10.1158/1055-9965.EPI-16-0891. Epub 2017 Jan 17.
8
Non-alcoholic fatty pancreas disease.
Postgrad Med J. 2017 Apr;93(1098):226-230. doi: 10.1136/postgradmedj-2016-134546. Epub 2017 Jan 9.
9
Cancer Statistics, 2017.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
10
Islet inflammation in type 2 diabetes and physiology.
J Clin Invest. 2017 Jan 3;127(1):14-23. doi: 10.1172/JCI88877.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验